Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2 by Emilien Ezine, Céleste Lebbe, Nicolas Dumaz

Get full text

European Journal of Skin Cancer Editorial by Dirk Schadendorf, Celeste Lebbe, Paul Lorigan, Susana Puig

Get full text

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy by Ahlem Jebali, Maxime Battistella, Céleste Lebbé, Nicolas Dumaz

Get full text

Pigmented Bowen’s disease presenting with a “starburst” pattern by Maione Vincenzo, Enzo Errichetti, Sara Laurent Roussel, Celeste Lebbé

Get full text

Update on the treatment of BRAFmut metastatic melanoma and future perspectives by Peter Mohr, Inès Nakouri, Sylvie Pfersch, François Denjean, Celeste Lebbé

Get full text

Bortezomib Does Not Prevent the Occurrence of Kaposi’s Sarcoma in Patients with Haematological Malignancies: Two Case Reports by Nathalie Chavarot, Celeste Lebbe, Eric Thervet, Didier Bouscary, Alexandre Karras

Get full text

Case Report: Clinical Experience With Avelumab in Patients With Metastatic Merkel Cell Carcinoma and Brain Metastases Treated in Europe by Kate Fife, Pauline Tétu, Jessica Prabhakaran, Celeste Lebbé, Giovanni Grignani

Get full text

Erratum to “Line-field confocal optical coherence tomography (LC-OCT) features of a melanotic macule of the lip” EJC Skin Cancer 2 (2024) 100016 by Barouyr Baroudjian, Clothilde Raoux, Perla El Zeinaty, Camille Gandon, Celeste Lebbé

Get full text

Line-field confocal optical coherence tomography (LC-OCT) features of a melanotic macule of the lip by Barouyr Baroudjian, Clothilde Raoux, Perla El Zeinaty, Camille Gandon, Celeste Lebbé

Get full text

New Vision in Photoprotection and Photorepair by Marie-Therese Leccia, Celeste Lebbe, Jean-Paul Claudel, Mridvika Narda, Nicole Basset-Seguin

Get full text

Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients by Aline Rangel-Pozzo, Janine Wechsler, Jessica Groult, Laetitia Da Meda, Celeste Lebbe, Sabine Mai

Get full text

Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance by Coralie Reger de Moura, Coralie Reger de Moura, Marco Prunotto, Anjum Sohail, Maxime Battistella, Maxime Battistella, Fanelie Jouenne, Fanelie Jouenne, Daniel Marbach, Celeste Lebbé, Celeste Lebbé, Rafael Fridman, Samia Mourah, Samia Mourah

Get full text

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study by Florian Herms, Barouyr Baroudjian, Julie Delyon, Pauline Laly, Pauline Tetu, Celeste Lebbe, Nicole Basset-Seguin

Get full text

A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling. by Celeste Lebbe, Mickael Guedj, Nicole Basset-Seguin, Marie Pierre Podgorniak, Suzanne Menashi, Anne Janin, Samia Mourah

Get full text

Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. by Stéphanie Dupuy, Marion Lambert, David Zucman, Siméon-Pierre Choukem, Sara Tognarelli, Cécile Pages, Céleste Lebbé, Sophie Caillat-Zucman

Get full text

The “Personalising Actinic Keratosis Treatment for Immunocompromised Patients” (IM-PAKT) Project: An Expert Panel Opinion by Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F. L. Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal

Get full text

PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors by Julie Delyon, Selma Becherirat, Anissa Roger, Mélanie Bernard-Cacciarella, Coralie Reger De Moura, Baptiste Louveau, Samia Mourah, Céleste Lebbé, Nicolas Dumaz

Get full text

Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis by Fanélie Jouenne, Jérôme Le Goff, Emmanuelle Bugnet, Maud Salmona, Véronique Meignin, Gwenaël Lorillon, Aurélie Sadoux, Janine Cherot, Céleste Lebbé, Samia Mourah, Abdellatif Tazi

Get full text

EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2. by Faten Bougatef, Suzanne Menashi, Farah Khayati, Benyoussef Naïmi, Raphaël Porcher, Marie-Pierre Podgorniak, Guy Millot, Anne Janin, Fabien Calvo, Céleste Lebbé, Samia Mourah

Get full text

Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients by Barouyr Baroudjian, Celeste Lebbe, Stefania Cuzzubbo, Pauline Tetu, Sarah Guegan, Renata Ursu, Catherine Belin, Lila Sirven Villaros, Julie Mazoyer, Coralie Lheure, Antoine F Carpentier

Get full text